Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for colorectal cancer patients with hidden cancer cells

NCT ID NCT07023289

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 26 times

Summary

This study tests a new drug, telisotuzumab adizutecan, against standard care in about 140 adults with colorectal cancer who have completed initial treatment but still have cancer DNA in their blood (ctDNA positive) with no visible tumors on scans. The goal is to see if the new drug can delay cancer return better than current options. Participants receive either the new drug or standard care by IV, and are monitored for side effects and cancer recurrence.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aarhus Universitetshospital - Skejby /ID# 274498

    RECRUITING

    Aarhus, Central Jutland, 8200, Denmark

  • Aichi Cancer Center /ID# 275479

    RECRUITING

    Nagoya, Aichi-ken, 464-8681, Japan

  • Asan Medical Center /ID# 274454

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 05505, South Korea

  • Azienda Ospedaliera Universitaria Luigi Vanvitelli /ID# 273540

    RECRUITING

    Naples, Napoli, 80138, Italy

  • Azienda Ospedaliero Universitaria Careggi /ID# 273604

    RECRUITING

    Florence, Firenze, 50134, Italy

  • China Medical University Hospital /ID# 274644

    RECRUITING

    Taichung, 40447, Taiwan

  • Clearview Cancer Institute - Huntsville - Cci Drive /ID# 278621

    RECRUITING

    Huntsville, Alabama, 35805, United States

  • Gifu University Hospital /ID# 274179

    RECRUITING

    Gifu, Gifu, 501-1194, Japan

  • Hospital Universitario La Paz /ID# 273718

    RECRUITING

    Madrid, 28046, Spain

  • Hospital Universitario Virgen del Rocio /ID# 273720

    RECRUITING

    Seville, Sevilla, 41013, Spain

  • Hospital Universitario de Salamanca /ID# 273719

    RECRUITING

    Salamanca, 37007, Spain

  • IRCCS Istituto Clinico Humanitas /ID# 273566

    RECRUITING

    Rozzano, Lombardy, 20089, Italy

  • Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • Johns Hopkins Hospital /ID# 275645

    RECRUITING

    Baltimore, Maryland, 21287, United States

  • Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 273745

    RECRUITING

    Kaohsiung City, 807, Taiwan

  • Kyushu University Hospital /ID# 273710

    RECRUITING

    Fukuoka, Fukuoka, 812-8582, Japan

  • Mayo Clinic Hospital Jacksonville /ID# 274472

    RECRUITING

    Jacksonville, Florida, 32224, United States

  • Mayo Clinic-Rochester /ID# 273508

    RECRUITING

    Rochester, Minnesota, 55905, United States

  • Moffitt Cancer Center /ID# 274372

    RECRUITING

    Tampa, Florida, 33612, United States

  • National Hospital Organization Osaka National Hospital /ID# 274306

    RECRUITING

    Osaka, Osaka, 540-0006, Japan

  • National Taiwan University Hospital /ID# 273580

    RECRUITING

    Taipei, 100, Taiwan

  • Northwell Health Center for Advanced Medicine. /ID# 275331

    RECRUITING

    Lake Success, New York, 11042, United States

  • Northwest Cancer Specialists /ID# 275151

    RECRUITING

    Portland, Oregon, 97227-1800, United States

  • Odense University Hospital /ID# 274970

    RECRUITING

    Odense C, Region Syddanmark, 5000, Denmark

  • Providence Medical Foundation /ID# 274207

    RECRUITING

    Fullerton, California, 92835-3826, United States

  • SCRI Oncology Partners /ID# 274522

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • Samsung Medical Center /ID# 274452

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 06351, South Korea

  • Scri Minnesota Oncology Hematology, P.A. /ID# 275149

    RECRUITING

    Minneapolis, Minnesota, 55404, United States

  • Seoul National University Hospital /ID# 274451

    RECRUITING

    Seoul, Seoul Teugbyeolsi, 03080, South Korea

  • Shizuoka Cancer Center /ID# 275480

    RECRUITING

    Sunto-gun, Shizuoka, 411-8777, Japan

  • Texas Oncology - Central/South Texas /ID# 275154

    RECRUITING

    Austin, Texas, 78705, United States

  • Texas Oncology-Grapevine /ID# 275155

    RECRUITING

    Grapevine, Texas, 76051, United States

  • The Center For Cancer And Blood Disorders /ID# 278512

    RECRUITING

    Fort Worth, Texas, 76104, United States

  • The University of Texas MD Anderson Cancer Center /ID# 273539

    RECRUITING

    Houston, Texas, 77030, United States

  • Tohoku University Hospital /ID# 275481

    RECRUITING

    Sendai, Miyagi, 980-8574, Japan

  • USC Norris Comprehensive Cancer Center /ID# 274550

    RECRUITING

    Los Angeles, California, 90033, United States

  • University Of Michigan /ID# 273511

    RECRUITING

    Ann Arbor, Michigan, 48109-5000, United States

  • University of Chicago Medical Center /ID# 274742

    RECRUITING

    Chicago, Illinois, 60637, United States

  • Vejle Sygehus /ID# 274368

    RECRUITING

    Vejle, Region Syddanmark, 7100, Denmark

  • Virginia Cancer Specialists - Fairfax /ID# 274339

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • Yokohama City University Medical Center /ID# 273657

    RECRUITING

    Yokohama, Kanagawa, 232-0024, Japan

Conditions

Explore the condition pages connected to this study.

COLORECTAL CANCER